Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Syntaxin 1 | 3 | 2021 | 30 | 2.230 |
Why?
|
Neuroendocrine Tumors | 4 | 2021 | 649 | 1.860 |
Why?
|
Receptors, Pituitary Hormone-Regulating Hormone | 3 | 2018 | 7 | 1.670 |
Why?
|
Receptors, Neuropeptide | 3 | 2018 | 105 | 1.560 |
Why?
|
Losartan | 2 | 2021 | 258 | 1.380 |
Why?
|
Colitis | 3 | 2022 | 1229 | 1.280 |
Why?
|
Apocrine Glands | 2 | 2018 | 32 | 1.180 |
Why?
|
Stomach Neoplasms | 5 | 2022 | 1423 | 1.050 |
Why?
|
Inflammatory Bowel Diseases | 6 | 2023 | 2421 | 1.030 |
Why?
|
Polyps | 2 | 2022 | 197 | 0.870 |
Why?
|
Gastric Fundus | 1 | 2022 | 37 | 0.810 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2022 | 46 | 0.780 |
Why?
|
Toluidines | 1 | 2020 | 21 | 0.730 |
Why?
|
Crotonates | 1 | 2020 | 21 | 0.730 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2021 | 35 | 0.730 |
Why?
|
Intestinal Polyps | 1 | 2021 | 104 | 0.730 |
Why?
|
Hydroxybutyrates | 1 | 2020 | 79 | 0.720 |
Why?
|
Uremia | 1 | 2021 | 201 | 0.710 |
Why?
|
Repressor Proteins | 2 | 2021 | 2978 | 0.700 |
Why?
|
Acetanilides | 1 | 2021 | 169 | 0.700 |
Why?
|
Gastritis | 1 | 2022 | 198 | 0.690 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2022 | 853 | 0.680 |
Why?
|
Colitis, Ulcerative | 2 | 2022 | 1919 | 0.670 |
Why?
|
Stomach Diseases | 1 | 2021 | 133 | 0.670 |
Why?
|
Gallbladder Neoplasms | 1 | 2021 | 190 | 0.650 |
Why?
|
Crohn Disease | 2 | 2022 | 2275 | 0.650 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2021 | 435 | 0.640 |
Why?
|
Duodenum | 2 | 2021 | 486 | 0.620 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2021 | 704 | 0.620 |
Why?
|
Neoplasms, Adnexal and Skin Appendage | 1 | 2018 | 27 | 0.590 |
Why?
|
Stomach | 2 | 2022 | 695 | 0.580 |
Why?
|
Breast Neoplasms | 9 | 2023 | 21065 | 0.560 |
Why?
|
Sweat Gland Neoplasms | 1 | 2018 | 117 | 0.530 |
Why?
|
Adenomyoepithelioma | 1 | 2015 | 2 | 0.530 |
Why?
|
Growth Hormone-Releasing Hormone | 1 | 2017 | 128 | 0.520 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2020 | 346 | 0.510 |
Why?
|
Nitriles | 1 | 2020 | 955 | 0.500 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2020 | 556 | 0.490 |
Why?
|
Carcinoma in Situ | 1 | 2021 | 796 | 0.490 |
Why?
|
Immunophenotyping | 1 | 2020 | 1870 | 0.490 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2016 | 192 | 0.460 |
Why?
|
Thiazoles | 1 | 2021 | 1509 | 0.460 |
Why?
|
Gastritis, Atrophic | 3 | 2022 | 31 | 0.450 |
Why?
|
Neoplasms, Second Primary | 1 | 2021 | 1060 | 0.430 |
Why?
|
Neprilysin | 1 | 2015 | 472 | 0.420 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2021 | 2296 | 0.410 |
Why?
|
Mammary Glands, Human | 1 | 2014 | 204 | 0.410 |
Why?
|
Hyperplasia | 5 | 2023 | 1158 | 0.380 |
Why?
|
Epithelial Cells | 3 | 2018 | 3665 | 0.370 |
Why?
|
Precancerous Conditions | 3 | 2022 | 978 | 0.360 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2022 | 218 | 0.350 |
Why?
|
Adenocarcinoma | 3 | 2023 | 6310 | 0.340 |
Why?
|
Breast | 2 | 2015 | 1980 | 0.340 |
Why?
|
Carcinoma | 2 | 2021 | 2334 | 0.340 |
Why?
|
Cardiomyopathies | 1 | 2021 | 1945 | 0.330 |
Why?
|
Immunohistochemistry | 7 | 2020 | 11064 | 0.330 |
Why?
|
Radiotherapy | 1 | 2016 | 1505 | 0.320 |
Why?
|
Fibrosis | 1 | 2016 | 2042 | 0.310 |
Why?
|
Gastric Mucosa | 2 | 2022 | 599 | 0.310 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1956 | 0.300 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4168 | 0.290 |
Why?
|
Ki-67 Antigen | 3 | 2014 | 631 | 0.290 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13249 | 0.290 |
Why?
|
Neoadjuvant Therapy | 2 | 2017 | 2811 | 0.270 |
Why?
|
Lymph Nodes | 1 | 2017 | 3491 | 0.250 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2804 | 0.250 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2021 | 474 | 0.210 |
Why?
|
Metaplasia | 3 | 2022 | 320 | 0.210 |
Why?
|
Gallbladder | 2 | 2022 | 305 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2021 | 478 | 0.210 |
Why?
|
Parietal Cells, Gastric | 1 | 2022 | 44 | 0.200 |
Why?
|
Chymases | 1 | 2021 | 73 | 0.200 |
Why?
|
Adrenergic beta-3 Receptor Agonists | 1 | 2021 | 14 | 0.200 |
Why?
|
Biopsy | 6 | 2022 | 6775 | 0.200 |
Why?
|
Rats | 5 | 2021 | 23695 | 0.190 |
Why?
|
Smad2 Protein | 1 | 2021 | 145 | 0.190 |
Why?
|
Smad3 Protein | 1 | 2021 | 168 | 0.190 |
Why?
|
Duodenal Neoplasms | 1 | 2021 | 113 | 0.190 |
Why?
|
Adenomatous Polyps | 1 | 2022 | 108 | 0.190 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2022 | 127 | 0.190 |
Why?
|
Ischemic Preconditioning | 1 | 2021 | 89 | 0.190 |
Why?
|
Rats, Wistar | 2 | 2021 | 1849 | 0.180 |
Why?
|
Biliary Tract Neoplasms | 1 | 2022 | 184 | 0.180 |
Why?
|
Alcohol Oxidoreductases | 1 | 2021 | 169 | 0.180 |
Why?
|
Heart Failure | 2 | 2022 | 11835 | 0.180 |
Why?
|
Barrett Esophagus | 2 | 2021 | 490 | 0.180 |
Why?
|
Chromogranin A | 1 | 2020 | 49 | 0.180 |
Why?
|
Diagnosis, Differential | 4 | 2021 | 12968 | 0.170 |
Why?
|
Synaptophysin | 1 | 2020 | 139 | 0.170 |
Why?
|
RNA-Binding Protein EWS | 1 | 2021 | 210 | 0.170 |
Why?
|
Humans | 34 | 2023 | 760261 | 0.170 |
Why?
|
Republic of Korea | 1 | 2021 | 567 | 0.160 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2023 | 517 | 0.160 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2021 | 231 | 0.160 |
Why?
|
Retrospective Studies | 9 | 2022 | 80301 | 0.160 |
Why?
|
Helicobacter pylori | 1 | 2021 | 377 | 0.150 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 6855 | 0.150 |
Why?
|
Helicobacter Infections | 1 | 2021 | 386 | 0.150 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 2 | 2015 | 938 | 0.150 |
Why?
|
Aneuploidy | 1 | 2021 | 551 | 0.150 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2021 | 479 | 0.150 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2021 | 613 | 0.150 |
Why?
|
Exanthema | 1 | 2022 | 504 | 0.140 |
Why?
|
DNA, Neoplasm | 1 | 2021 | 1745 | 0.130 |
Why?
|
Female | 18 | 2023 | 391011 | 0.130 |
Why?
|
Nephrectomy | 1 | 2021 | 1017 | 0.130 |
Why?
|
Transcription Factors | 1 | 2015 | 12100 | 0.130 |
Why?
|
Radiation Injuries, Experimental | 1 | 2016 | 88 | 0.130 |
Why?
|
Fibrocystic Breast Disease | 1 | 2015 | 103 | 0.130 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 551 | 0.130 |
Why?
|
Esophagus | 1 | 2021 | 1023 | 0.120 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14656 | 0.120 |
Why?
|
Protective Agents | 1 | 2016 | 150 | 0.120 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 830 | 0.120 |
Why?
|
Axilla | 1 | 2017 | 618 | 0.120 |
Why?
|
ROC Curve | 1 | 2021 | 3568 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18134 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1591 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2449 | 0.110 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2017 | 727 | 0.100 |
Why?
|
Hematologic Diseases | 1 | 2016 | 497 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1189 | 0.100 |
Why?
|
Breast Diseases | 1 | 2015 | 443 | 0.100 |
Why?
|
Male | 12 | 2022 | 359413 | 0.100 |
Why?
|
Membrane Transport Proteins | 1 | 2018 | 1036 | 0.100 |
Why?
|
Cytomegalovirus | 1 | 2016 | 756 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2063 | 0.100 |
Why?
|
Receptors, Androgen | 1 | 2018 | 1075 | 0.100 |
Why?
|
Lymph Node Excision | 1 | 2017 | 1305 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8157 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2022 | 2526 | 0.090 |
Why?
|
Glycoproteins | 1 | 2018 | 2208 | 0.090 |
Why?
|
Adult | 8 | 2022 | 219847 | 0.090 |
Why?
|
Cytomegalovirus Infections | 1 | 2016 | 831 | 0.090 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3023 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2297 | 0.080 |
Why?
|
Carcinoma, Lobular | 1 | 2014 | 490 | 0.080 |
Why?
|
Prognosis | 2 | 2021 | 29636 | 0.080 |
Why?
|
Up-Regulation | 1 | 2017 | 4127 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2022 | 3960 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39254 | 0.070 |
Why?
|
Radiation Dosage | 1 | 2016 | 1957 | 0.070 |
Why?
|
Heart | 2 | 2021 | 4392 | 0.070 |
Why?
|
Animals | 6 | 2022 | 167940 | 0.070 |
Why?
|
Middle Aged | 7 | 2021 | 220175 | 0.070 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2014 | 1094 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4317 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7592 | 0.070 |
Why?
|
Observer Variation | 2 | 2022 | 2596 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2018 | 4938 | 0.060 |
Why?
|
Lung | 1 | 2022 | 9989 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2021 | 9590 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8498 | 0.060 |
Why?
|
Hungary | 1 | 2023 | 82 | 0.050 |
Why?
|
Receptor, erbB-2 | 1 | 2014 | 2544 | 0.050 |
Why?
|
Mammography | 1 | 2014 | 2452 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2020 | 7854 | 0.050 |
Why?
|
MicroRNAs | 1 | 2019 | 3784 | 0.050 |
Why?
|
Nitrosourea Compounds | 1 | 2022 | 32 | 0.050 |
Why?
|
Inflammation | 1 | 2022 | 10757 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15273 | 0.050 |
Why?
|
Apolipoprotein B-100 | 1 | 2022 | 155 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2014 | 10434 | 0.050 |
Why?
|
Organophosphorus Compounds | 1 | 2022 | 202 | 0.050 |
Why?
|
Flow Cytometry | 2 | 2021 | 5873 | 0.050 |
Why?
|
Aged | 5 | 2021 | 168995 | 0.050 |
Why?
|
Receptors, Leptin | 1 | 2022 | 350 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2017 | 11480 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 429 | 0.040 |
Why?
|
Phenylurea Compounds | 1 | 2022 | 529 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2014 | 12762 | 0.040 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1843 | 0.030 |
Why?
|
Epirubicin | 1 | 2014 | 83 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2021 | 867 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13505 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2023 | 2008 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3302 | 0.030 |
Why?
|
Colonoscopy | 1 | 2022 | 1387 | 0.030 |
Why?
|
Colon | 1 | 2021 | 1788 | 0.030 |
Why?
|
Antibodies, Antinuclear | 1 | 2013 | 344 | 0.030 |
Why?
|
Endoscopy | 1 | 2021 | 1841 | 0.020 |
Why?
|
Taxoids | 1 | 2014 | 668 | 0.020 |
Why?
|
Pyridines | 1 | 2022 | 2877 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 1656 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2014 | 872 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3826 | 0.020 |
Why?
|
Fluorouracil | 1 | 2014 | 1630 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8487 | 0.020 |
Why?
|
Oligopeptides | 1 | 2013 | 1188 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5513 | 0.020 |
Why?
|
Catheter Ablation | 1 | 2021 | 2755 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11708 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8314 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5790 | 0.020 |
Why?
|
Echocardiography | 1 | 2019 | 4980 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58947 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2016 | 3061 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22025 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7468 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 87747 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9388 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2023 | 17766 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24086 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 29950 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5644 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9196 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23363 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20048 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 64947 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 58673 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81216 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74269 | 0.010 |
Why?
|
Child | 1 | 2021 | 79758 | 0.010 |
Why?
|